- Home
- BDL vs NVNO Comparison
BDL vs NVNO Comparison
Compare BDL & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- NVNO
- Stock Information
- Founded
- BDL 1959
- NVNO 1987
- Country
- BDL United States
- NVNO United States
- Employees
- BDL N/A
- NVNO N/A
- Industry
- BDL Restaurants
- NVNO Medical/Dental Instruments
- Sector
- BDL Consumer Discretionary
- NVNO Health Care
- Exchange
- BDL Nasdaq
- NVNO Nasdaq
- Market Cap
- BDL 48.0M
- NVNO 51.7M
- IPO Year
- BDL N/A
- NVNO N/A
- Fundamental
- Price
- BDL $24.01
- NVNO $2.73
- Analyst Decision
- BDL
- NVNO
- Analyst Count
- BDL 0
- NVNO 0
- Target Price
- BDL N/A
- NVNO N/A
- AVG Volume (30 Days)
- BDL 2.3K
- NVNO 137.6K
- Earning Date
- BDL 02-11-2025
- NVNO 10-31-2024
- Dividend Yield
- BDL 2.05%
- NVNO N/A
- EPS Growth
- BDL N/A
- NVNO N/A
- EPS
- BDL 1.64
- NVNO N/A
- Revenue
- BDL $185,457,000.00
- NVNO N/A
- Revenue This Year
- BDL N/A
- NVNO N/A
- Revenue Next Year
- BDL N/A
- NVNO N/A
- P/E Ratio
- BDL $14.89
- NVNO N/A
- Revenue Growth
- BDL 8.71
- NVNO N/A
- 52 Week Low
- BDL $23.94
- NVNO $2.74
- 52 Week High
- BDL $29.72
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- BDL 35.83
- NVNO 30.94
- Support Level
- BDL $23.94
- NVNO $2.90
- Resistance Level
- BDL $25.25
- NVNO $2.93
- Average True Range (ATR)
- BDL 0.28
- NVNO 0.16
- MACD
- BDL -0.03
- NVNO -0.02
- Stochastic Oscillator
- BDL 4.49
- NVNO 5.45
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).